![After more than a decade, ASCO sells CancerLinQ to ConcertAI](https://cdn.cancerletter.com/media/2023/12/11100147/49-46-4x3-1.jpg)
![After more than a decade, ASCO sells CancerLinQ to ConcertAI](https://cdn.cancerletter.com/media/2023/12/11100147/49-46-4x3-1.jpg)
Cover Story
Free
ConcertAI, a company focused on real-world evidence and generative AI, has acquired CancerLinQ, a real-world data and quality of care technology service that was launched by the American Society of Clinical Oncology a decade ago.
Cancer History ProjectFree
By Alexandria Carolan and Katie Goldberg
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Funding Opportunities
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- “All in Her Head” catalogs the history of medicine’s atrocities against women
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - Chernobyl: a 35 year follow up on long-term health effects
- Suspensions, public outrage ensue as tensions over Middle East sweep through oncology
NYU Cancer Center Director Benjamin Neel suspended over social media posts - Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
- Prominent GI oncologist Axel Grothey was forced out of Mayo Clinic for unethical sexual relationships with women he mentored
Three reprimands later, he retains leadership—and mentorship—positions